No Data
No Data
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Express News | Ibio Expands Executive Leadership Team With Appointment of Kristi Sarno as Senior Vice President of Business Development
IBio Price Target Announced at $3.60/Share by Brookline Capital
IBio Initiated at Buy by Brookline Capital
Brookline Capital Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $3.6
IBio Files $150M Mixed Shelf Offering
No Data
Trytosaveabit : Sad isn’t it, how one can get a patent and goes 100%+ and another gets a very similar patent ( meaning in same field/type ) and can’t even get a bit of volume? Hehehe! In its defense though. Sometimes I’ve seen patent news take a day or 3 to move a tickers price? GL to ya![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)